ReviewNeoplasia (New York, N.Y.)2026

Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach.

Ann T Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.